Search the Newsreel

Oncology institute CMO Yale Podnos sells $150k in shares

Yale Podnos, Chief Medical Officer of Oncology Institute, Inc. (NASDAQ:TOI), recently sold $150,340 worth of common stock after exercising options. The sales were part of a Rule 10b5-1 trading plan. Despite the stock's recent decline, it remains up significantly over the past year, and …

Is Oncology Institute (TOI) One of the Best Future Stocks to Buy Under $10?

The Oncology Institute (TOI) recently completed a strategic refinancing deal with OrbiMed, securing a $75 million term loan and repaying its previous $86 million debt. This move is expected to strengthen its balance sheet, extend debt maturities, and improve liquidity without diluting existing shareholders. …

The Oncology Institute (TOI) Soars 5.3%: Is Further Upside Left in the Stock?

Oncology Institute chiefs to host B. Riley investor fireside chat

The Oncology Institute, Inc. (NASDAQ:TOI) Analysts Are Pretty Bullish On The Stock After Recent Results

The Oncology Institute, Inc. (NASDAQ:TOI) Released Earnings Last Week And Analysts Lifted Their Price Target To US$7.00

The Oncology Institute Inc. (TOI) stock rises on Q1 2026 Earnings

The Oncology Institute Reports First Quarter 2026 Financial Results

The Oncology Institute, Inc. (TOI) Reports Q1 Loss, Beats Revenue Estimates

Here’s What Powered The Oncology Institute’s (TOI) Gains

Oncology Institute’s Q4 Surprises Stir Investor Interest

Earnings call transcript: Oncology Institute Q4 2025 beats EPS estimates, stock rises

Investors Give The Oncology Institute, Inc. (NASDAQ:TOI) Shares A 26% Hiding

The Oncology Institute (TOI) Loses 20% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner